Patents by Inventor Pratik S. Multani

Pratik S. Multani has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHODS OF TREATING CANCER
    Publication number: 20220257592
    Abstract: Provided herein are methods of treating cancer in a patient in need thereof includes administering to the patient a therapeutically effective amount of entrectinib wherein the patient has impaired hepatic function and methods of managing adverse reactions of administration of entrectinib in a patient.
    Type: Application
    Filed: February 1, 2022
    Publication date: August 18, 2022
    Applicants: HOFFMANN-LA ROCHE INC., IGNYTA, INC., GENENTECH, INC.
    Inventors: Georgina Meneses-Lorente, Edna Chow Maneval, Pratik S. Multani, Susan Diane Eng, Sergio Rene Ley Acosta
  • METHODS OF TREATING ISCHEMIA
    Publication number: 20220054553
    Abstract: The invention provides compositions comprising stem and/or progenitor cells that have been treated to enhance the therapeutic properties of the cells for treating ischemia. In particular, the present invention relates to the use of stem and/or progenitor cells having enhanced therapeutic properties to treat an ischemic tissue, a tissue damaged by ischemia, or at least one symptom associated with an ischemic tissue or a tissue damaged by ischemia.
    Type: Application
    Filed: April 12, 2021
    Publication date: February 24, 2022
    Inventors: Dan Shoemaker, Pratik S. Multani, John D. Mendlein, David Robbins
  • Methods of treating ischemia
    Patent number: 10980838
    Abstract: The invention provides compositions comprising stem and/or progenitor cells that have been treated to enhance the therapeutic properties of the cells for treating ischemia. In particular, the present invention relates to the use of stem and/or progenitor cells having enhanced therapeutic properties to treat an ischemic tissue, a tissue damaged by ischemia, or at least one symptom associated with an ischemic tissue or a tissue damaged by ischemia.
    Type: Grant
    Filed: September 19, 2018
    Date of Patent: April 20, 2021
    Assignee: FATE THERAPEUTICS, INC.
    Inventors: Dan Shoemaker, Pratik S. Multani, John D. Mendlein, David Robbins
  • Methods for the treatment of cancer
    Patent number: 10799503
    Abstract: Disclosed herein are methods of treating cancer in a subject, wherein the subject is known to possess at least one genetic alteration in RET, comprising administering to the subject a therapeutically effective amount of N-[3-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl]-N?-[5-(2,2,2-trifluoro-1, 1-dimethylethyl)-3-isoxazolyl]-urea, or a pharmaceutically acceptable salt thereof.
    Type: Grant
    Filed: November 29, 2017
    Date of Patent: October 13, 2020
    Assignee: IGNYTA, INC.
    Inventors: Jonathan Ee-Ren Lim, Pratik S. Multani, Richard Landin, Rupal Patel, Jennifer Wright Oliver
  • METHODS FOR THE TREATMENT OF CANCER
    Publication number: 20200069688
    Abstract: Disclosed herein are methods of treating cancer in a subject, wherein the subject is known to possess at least one genetic alteration in RET, comprising administering to the subject a therapeutically effective amount of N-[3-[(6,7-dimethoxy-4-quinazolinyl)oxy]phenyl]-N?-[5-(2,2,2-trifluoro-1, 1-dimethylethyl)-3-isoxazolyl]-urea, or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: November 29, 2017
    Publication date: March 5, 2020
    Applicant: IGNYTA, INC.
    Inventors: Jonathan Ee-Ren Lim, Pratik S. Multani, Richard Landin, Rupal A. Patel, Jennifer Wright Oliver
  • METHODS OF TREATING ISCHEMIA
    Publication number: 20190015454
    Abstract: The invention provides compositions comprising stem and/or progenitor cells that have been treated to enhance the therapeutic properties of the cells for treating ischemia. In particular, the present invention relates to the use of stem and/or progenitor cells having enhanced therapeutic properties to treat an ischemic tissue, a tissue damaged by ischemia, or at least one symptom associated with an ischemic tissue or a tissue damaged by ischemia.
    Type: Application
    Filed: September 19, 2018
    Publication date: January 17, 2019
    Inventors: Dan Shoemaker, Pratik S. Multani, John D. Mendlein, David Robbins
  • Methods of treating ischemia
    Patent number: 10111907
    Abstract: The invention provides compositions comprising stem and/or progenitor cells that have been treated to enhance the therapeutic properties of the cells for treating ischemia. In particular, the present invention relates to the use of stem and/or progenitor cells having enhanced therapeutic properties to treat an ischemic tissue, a tissue damaged by ischemia, or at least one symptom associated with an ischemic tissue or a tissue damaged by ischemia.
    Type: Grant
    Filed: November 29, 2012
    Date of Patent: October 30, 2018
    Assignee: Fate Therapeutics, Inc.
    Inventors: Dan Shoemaker, Pratik S. Multani, John D. Mendlein, David Robbins
  • METHODS OF TREATING ISCHEMIA
    Publication number: 20140348802
    Abstract: The invention provides compositions comprising stem and/or progenitor cells that have been treated to enhance the therapeutic properties of the cells for treating ischemia. In particular, the present invention relates to the use of stem and/or progenitor cells having enhanced therapeutic properties to treat an ischemic tissue, a tissue damaged by ischemia, or at least one symptom associated with an ischemic tissue or a tissue damaged by ischemia.
    Type: Application
    Filed: November 29, 2012
    Publication date: November 27, 2014
    Inventors: Dan Shoemaker, Pratik S. Multani, John D. Mendlein, David Robbins
  • Cancer Treatments
    Publication number: 20090209606
    Abstract: Methods and compositions for treating cancers characterized by death-resistant cancer cells are described. In general, such methods involve administration of a therapeutically effective amount of a compound that induces mitotic catastrophe in the some, and preferably most or all, of the cancerous cells. Methods for assessing the efficacy of such treatments are also provided.
    Type: Application
    Filed: February 18, 2009
    Publication date: August 20, 2009
    Inventors: Heather Helene Bendall, Gary T. Elliott, Lorenzo M. Leoni, Christina Carol Niemeyer, Pratik S. Multani